Kent Berkley is an Investor at Frazier Healthcare Partners, whose known portfolio counts 10 companies.
Is Kent Berkley a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Stage
- Late-Stage
- Sector
- Healthcare
- Focus
- BiotechDiagnosticsDrug DiscoveryGenomicsGrowth BuyoutMedTechMedical DevicesPharma
Contacts
Affiliated funds' portfolios
Investor at Frazier Healthcare Partners, whose known portfolio counts 10 companies
- Metagenomi
- New Amsterdam Pharma
- Day One Biopharmaceuticals
- Pardes Biosciences
- Tricida
- Curve Beam
- Iolyx Therapeutics
- Knipper Health
- SanReno Therapeutics
- Silence Therapeutics
Investor Profile
The listing covers sector Healthcare, and focus areas Biotech, Diagnostics, Drug Discovery and Genomics. Startups operating in these areas may find Kent Berkley relevant.
Stage-wise, the deals at Frazier Healthcare Partners cluster around Late-Stage rounds.
The firm portfolio and the focus above give founders context on whether Kent Berkley matches their raise.
Colleagues at Frazier Healthcare Partners
John Payton
Investor
Seattle, United States
Michael Machak
Investor
Seattle, United States
Shyamal Swami
Investor
Seattle, United States
Brian Morfitt
Investor
Seattle, United States
Clarissa Berman
Investment Professional
Seattle, United States
Christina Reszka
Investor
Seattle, United States
Steve B.
Investor
Austin, United States
Ryan Lucero
Investor
Seattle, United States
Matthew Hinshaw
Investor
Seattle, United States
Nathan Every
Investor
Seattle, United States
Ben Magnano
Investor
Seattle, United States
Frequently asked questions
Who is Kent Berkley?
Kent Berkley is a private equity investor and venture debt investor based in Seattle, Washington, United States, listed as Investor at Frazier Healthcare Partners. The known portfolio of that firm counts 10 companies. That portfolio belongs to the firm, not to Kent Berkley personally.
What does Kent Berkley invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Diagnostics, Drug Discovery and Genomics. Those tags come from the portfolios of the firms this profile is attached to, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Kent Berkley invest at?
Frazier Healthcare Partners appears in Late-Stage rounds across its known deals, and Kent Berkley is listed there as Investor. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
Which firm is Kent Berkley listed at?
Kent Berkley is listed as Investor at Frazier Healthcare Partners. 11 other people in the database share a firm with Kent Berkley.
How do I contact Kent Berkley?
An email address, a phone number and a LinkedIn page are on file for Kent Berkley. The address stays masked on this page and is readable inside RaiseHunt after you create an account.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal